Disclaimer: This article is for research and educational purposes only
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation
Its short half-life makes it highly controllable
What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
For example, those with Crohns disease or after gastric bypass might not absorb Vitamin B12 well
Metabolic research focus: Examined in obese rodent studies for changes in weight gain patterns, fat oxidation, and markers associated with lipolysis and lipogenesis